These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6830263)

  • 1. Localization of the disulfide bond in human antithrombin III required for heparin-accelerated thrombin inactivation.
    Ferguson WS; Finlay TH
    Arch Biochem Biophys; 1983 Feb; 221(1):304-7. PubMed ID: 6830263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disulfide bond in antithrombin is required for heparin-accelerated thrombin inactivation.
    Longas MO; Ferguson WS; Finlay TH
    J Biol Chem; 1980 Apr; 255(8):3436-41. PubMed ID: 7364749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-formation of disulphide bonds in reduced antithrombin III.
    Sun XJ; Chang JY
    Biochem J; 1990 Aug; 269(3):665-9. PubMed ID: 2390061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III.
    Griffith MJ; Noyes CM; Church FC
    J Biol Chem; 1985 Feb; 260(4):2218-25. PubMed ID: 3838304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin binding domain of human antithrombin III inferred from the sequential reduction of its three disulfide linkages. An efficient method for structural analysis of partially reduced proteins.
    Sun XJ; Chang JY
    J Biol Chem; 1989 Jul; 264(19):11288-93. PubMed ID: 2544589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin on thrombin inactivation by antithrombin-III.
    Machovich R; Arányi P
    Biochem J; 1978 Sep; 173(3):869-75. PubMed ID: 708377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of heparin to human antithrombin III activates selective chemical modification at lysine 236. Lys-107, Lys-125, and Lys-136 are situated within the heparin-binding site of antithrombin III.
    Chang JY
    J Biol Chem; 1989 Feb; 264(6):3111-5. PubMed ID: 2492530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
    Oshima G; Nagai T; Nagasawa K
    Thromb Res; 1984 Sep; 35(6):601-11. PubMed ID: 6209818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin.
    Machovich R; Blaskó G; Borsodi A
    Thromb Haemost; 1976 Dec; 36(3):503-8. PubMed ID: 65798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location of disulfide bonds in antithrombin III.
    Zhou ZR; Smith DL
    Biomed Environ Mass Spectrom; 1990 Dec; 19(12):782-6. PubMed ID: 2088576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
    Hogg PJ; Jackson CM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.
    Austin RC; Sheffield WP; Rachubinski RA; Blajchman MA
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):345-51. PubMed ID: 1546950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of esterase and amidase activities of alpha- and beta-thrombin in the presence of antithrombin III and heparin.
    Borsodi A; Machovich R
    Biochim Biophys Acta; 1979 Feb; 566(2):385-9. PubMed ID: 570423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of NaC1 on inactivation of bovine thrombin by antithrombin III in the presence of low affinity-heparin or dextran sulfate.
    Oshima G; Nagasawa K
    Thromb Res; 1986 Feb; 41(3):361-72. PubMed ID: 2422780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin III].
    Boyer-Neumann C; Wolf M; Larrieu MJ
    Ann Biol Clin (Paris); 1987; 45(2):175-80. PubMed ID: 3619143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III.
    Hoylaerts M; Owen WG; Collen D
    J Biol Chem; 1984 May; 259(9):5670-7. PubMed ID: 6715365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.